Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Monitoring Oedema in Heart Failure to Improve Function and Reduce Hospitalisation Risk

NCT: NCT07067658 · RECRUITING

NCT IDNCT07067658
StatusRECRUITING
Start Date2025-12-18
Completion2027-07-31
SponsorHeartfelt Technologies (INDUSTRY)
First posted
Last updated

Brief Summary

This study will evaluate the Heartfelt device, a novel, passive monitoring system that detects early signs of fluid build-up in patients (oedema) with heart failure by measuring changes in foot and lower leg volume through capture of 3D images. The trial will assess whether this device, when added to standard NHS care, improves quality of life and reduces heart failure-related events compared to standard care alone.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑